Since the completion of the original Human Genome Project using Sanger sequencing in 2001, there have been many advances in sequencing technologies. Most recently, the invention of Next Generation Sequencing (NGS) is allowing laboratories to use whole genome sequencing in a clinical application.1 Today, there are many different platforms to perform NGS and competition between companies has lowered the cost of this application.1 The incorporation of this type of testing into the diagnostic world will be one of the main contributions to providing personalized, unique healthcare to patients.¹